Ruth Prassl
Impact in
- Pharmaceutical Science top 1%
- Advanced Drug Delivery Systems
- Microbiology top 1%
- Bacterial Infections and Vaccines
Papers in
- Biomaterials 19
- Nanoparticle-Based Drug Delivery 15
-
- Antioxidant Activity and Oxidative Stress 7
- Co-authors
- Peter LaggnerBrigitte StarkHarald ManggeJoachim ReidlGeorg PabstStefan SchildAnna GriesFranz G. Zingl
In The Last Decade
Ruth Prassl
86 papers receiving 3.5k citations
Hit Papers
Peers
Comparison fields: 5 of 151
- Pharmaceutical Science 332
- Microbiology 322
- Biomaterials 546
- Biological Psychiatry 92
- Molecular Biology 1.5k
Countries citing papers authored by Ruth Prassl
This map shows the geographic impact of Ruth Prassl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruth Prassl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruth Prassl more than expected).
Fields of papers citing papers by Ruth Prassl
This network shows the impact of papers produced by Ruth Prassl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruth Prassl. The network helps show where Ruth Prassl may publish in the future.
Co-authors
The 25 scholars most cited alongside Ruth Prassl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2024 | 5 | |
| 3 | 2024 | 5 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 8 | |
| 6 | 2022 | 9 | |
| 7 | 2022 | 16 | |
| 8 | 2020 | 23 | |
| 9 | 2019 | 18 | |
| 10 | 2019 | 13 | |
| 11 | 2019 | 79 | |
| 12 | 2015 | 38 | |
| 13 | 2013 | 105 | |
| 14 | 2013 | 38 | |
| 15 | 2012 | 10 | |
| 16 | 2010 | 170 | |
| 17 | 2008 | 5 | |
| 18 | 2006 | 37 | |
| 19 | 2004 | 63 | |
| 20 | 1999 | 247 |
About Ruth Prassl
Ruth Prassl is a scholar working on Biomaterials, Biochemistry, Pharmaceutical Science, Cancer Research and Structural Biology, having authored 87 papers that have together received 3.6k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (15 papers), Lipid Membrane Structure and Behavior (11 papers), RNA Interference and Gene Delivery (9 papers), Atherosclerosis and Cardiovascular Diseases (7 papers), Antioxidant Activity and Oxidative Stress (7 papers), Protein Structure and Dynamics (6 papers), Systemic Lupus Erythematosus Research (6 papers) and Advanced Drug Delivery Systems (6 papers). The work is most often cited by research in Pharmaceutical Science (332 citations), Microbiology (322 citations), Biomaterials (546 citations), Biological Psychiatry (92 citations) and Molecular Biology (1.5k citations). Ruth Prassl has collaborated with scholars based in Austria, France and Germany. Frequent co-authors include Peter Laggner, Brigitte Stark, Harald Mangge, Joachim Reidl, Georg Pabst, Stefan Schild, Anna Gries, Franz G. Zingl, Gerhard M. Kostner and Gunter Almer. Their work appears in journals such as International Journal of Nanomedicine, Journal of Biological Chemistry, Biochemistry, European Journal of Pharmaceutics and Biopharmaceutics and Journal of Controlled Release.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.